ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2025
Correlatıon between PET-CT uptake values and pathologıcaly features ın head and neck cancer.
Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo evaluate the correlation between SUV-Max values and pathological outcomes in head and neck squamous cell carcinoma (HNSCC) and determine the predictive power of SUV-Max for disease prognosis. DATA SOURCES: Retrospective analysis of medical records and PET-CT imaging results from patients diagnosed with HNSCC at our institution between 2014 and 2023. REVIEW
methodsExamination of SUV-Max values from F18-FDG PET-CT scans and their association with pathological findings such as perineural invasion, lymphovascular invasion, and neck lymph node metastasis. Statistical analysis was conducted to establish cutoff values and assess the significance of correlations.
resultsOur study identified significant cutoff values for PET-CT SUV-Max that correlate with the pathological features of head and neck cancer. For primary tumors, a SUV-Max cutoff of 14.71 predicted neck metastasis with a sensitivity of 67.6% and specificity of 64.2%, demonstrating moderate diagnostic accuracy with an AUC of 0.648. Perineural invasion was optimally predicted at a cutoff of 13.28, with a sensitivity of 74%, specificity of 67.3%, and an AUC of 0.728. Similarly, a cutoff of 13.28 for lymphovascular invasion yielded a sensitivity and specificity of 63%, with an AUC of 0.628. Additionally, neck lymph node metastasis was effectively assessed with a SUV-Max cutoff of 2.74, achieving a sensitivity of 62.2%, specificity of 67%, and an AUC of 0.694. These cutoff values highlight the potential of SUV-Max in enhancing diagnostic precision for both primary tumors and lymph node assessments in head and neck oncology.
conclusionSUV-Max values from PET-CT scans are significant predictors of pathological outcomes in HNSCC, aiding in the stratification of patient prognosis and guiding clinical decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.